Tagworks will present the latest developments of their click-cleavable ADC technology at the ACS National Meeting in San Diego, taking place on the 25th-29th August. www.acs.org/content/acs/en/meetings/national-meeting  

Tagworks will present the latest developments of their click-to-release technology at the 55th International Conference on Medicinal Chemistry - Interfacing Chemical Biology and Drug Discovery - in  Nantes, France, taking place on the 3rd-5th July. www.rict2019.org

Tagworks will present the click-cleavable ADC technology at the CHAINS meeting in Veldhoven, taking place on the 3rd-5th December. www.nwochains.nl  

Tagworks will present the click-cleavable ADC technology at the Word ADC meeting in San Diego, taking place on the 12th-15st November.http://worldadc-usa.com

Tagworks will present the click-cleavable ADC technology at the European Antibody Congress, taking place on the 29th-31st October in Basel. http://www.terrapinn.com/conference/european-antibody-congress/index.stm

Tagworks reports that the scope of its proprietary click-to-release reaction can be expanded from the cleavage of carbamates to ethers, potentially allowing more drug types to be released from their click-cleavable ADCs. https://doi.org/10.1002/anie.201800402

In mouse models of ovarian and aggressive colon cancer, Tagworks Pharmaceuticals has demonstrated the potent antitumour effect of the company's 'click-to-release' bioorthogonal chemistry approach. The results are published in the journal Nature Communications Raffaella Rossin, et al., Chemically triggered drug release from an antibody-drug conjugate leads to potent antitumour activity …

Tagworks' CEO Marc Robillard is one of the speakers at Antibody Engineering & Therapeutics Europe 2018 in Amsterdam from 5-7 June. Marc will present the company's latest results on "Click chemistry-triggered drug release from a tumor-bound ADC" on Thursday 7 June. His lecture is part of a session on "Novel …

Tagworks CEO Marc Robillard talks about entrepreneurship in the life sciences field and shares his experiences as co-founder of Tagworks Pharmaceuticals during the InnoBoot Session: Business meets Science at the StartupDelta Summit on Thursday April 19, 2018, in Arnhem, the Netherlands. More information on the event: https://startupdeltasummit.com/overdesummit/

Tagworks CSO Raffaella Rossin presents the company's latest research achievements on 'In vivo click chemistry' at the 19th European Symposium on Radiopharmacy and Radiopharmaceuticals (ESRR) in Groningen, the Netherlands on Friday, April 6, 2018. More information: http://www.esrr.info/welcome-address/